These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37631871)

  • 1. Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix
    Chauwa A; Bosomprah S; Laban NM; Phiri B; Chibuye M; Chilyabanyama ON; Munsaka S; Simuyandi M; Mwape I; Mubanga C; Chobe MC; Chisenga C; Chilengi R
    Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants.
    El-Heneidy A; Cheung C; Lambert SB; Wang CYT; Whiley DM; Sly PD; Ware RS; Grimwood K
    Pathology; 2022 Dec; 54(7):928-934. PubMed ID: 35817636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Histo-Blood Group Antigen Status in Mother-Infant Dyads and Infant Oral Rotavirus Vaccine Immunogenicity in rural Zimbabwe.
    Pun J; Evans C; Chasekwa B; Church JA; Gough E; Mutasa K; Rukobo S; Govha M; Mushayanembwa P; Majo FD; Tavengwa NV; Humphrey JH; Kirkpatrick BD; Kosek M; Ntozini R; Prendergast AJ
    J Infect Dis; 2024 Oct; ():. PubMed ID: 39352457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.
    Pollock L; Bennett A; Jere KC; Dube Q; Mandolo J; Bar-Zeev N; Heyderman RS; Cunliffe NA; Iturriza-Gomara M
    Clin Infect Dis; 2019 Sep; 69(8):1313-1319. PubMed ID: 30561537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants.
    Bucardo F; Reyes Y; Rönnelid Y; González F; Sharma S; Svensson L; Nordgren J
    Sci Rep; 2019 Jul; 9(1):10764. PubMed ID: 31341254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
    Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ROTARIX
    Laban NM; Bosomprah S; Simuyandi M; Chibuye M; Chauwa A; Chirwa-Chobe M; Sukwa N; Chipeta C; Velu R; Njekwa K; Mubanga C; Mwape I; Goodier MR; Chilengi R
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
    Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
    Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
    Donato CM; Handley A; Byars SG; Bogdanovic-Sakran N; Lyons EA; Watts E; Ong DS; Pavlic D; At Thobari J; Satria CD; Nirwati H; Soenarto Y; Bines JE
    J Infect Dis; 2024 Apr; 229(4):1010-1018. PubMed ID: 37592804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
    Miya TV; Groome MJ; de Assis Rosa D
    Vaccine; 2021 Nov; 39(48):7028-7035. PubMed ID: 34740476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
    Boniface K; Byars SG; Cowley D; Kirkwood CD; Bines JE
    J Infect Dis; 2020 Mar; 221(7):1070-1078. PubMed ID: 31763671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
    Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
    Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner.
    Nordgren J; Sharma S; Bucardo F; Nasir W; Günaydın G; Ouermi D; Nitiema LW; Becker-Dreps S; Simpore J; Hammarström L; Larson G; Svensson L
    Clin Infect Dis; 2014 Dec; 59(11):1567-73. PubMed ID: 25097083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
    Kazimbaya KM; Chisenga CC; Simuyandi M; Phiri CM; Laban NM; Bosomprah S; Permar SR; Munsaka S; Chilengi R
    PLoS One; 2020; 15(11):e0240714. PubMed ID: 33170860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
    Kazi AM; Cortese MM; Yu Y; Lopman B; Morrow AL; Fleming JA; McNeal MM; Steele AD; Parashar UD; Zaidi AKM; Ali A
    J Infect Dis; 2017 Mar; 215(5):786-789. PubMed ID: 28329092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
    Williams FB; Kader A; Colgate ER; Dickson DM; Carmolli M; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Petri WA; Haque R; Qadri F; Kirkpatrick BD; Lee B
    J Infect Dis; 2021 Oct; 224(7):1147-1151. PubMed ID: 32157282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
    Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
    Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    Armah GE; Cortese MM; Dennis FE; Yu Y; Morrow AL; McNeal MM; Lewis KDC; Awuni DA; Armachie J; Parashar UD
    J Infect Dis; 2019 Feb; 219(5):746-749. PubMed ID: 30357332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.